Skip to main content
. 2020 Jan 14;9:4. doi: 10.1186/s40169-020-0257-2

Table 1.

Demographic and clinicopathologic features of the study cohorts

Demographic features Cancer (n = 92) Control (n = 33) p
Average age (range), year 63 (15–89) 54 (21–81) 0.001
Gender
 Male (%) 78 (85%) 20 (61%)
 Female (%) 14 (15%) 13 (39%) 0.008
Pathology Cancer (n = 92) Control (n = 33)
Stage
 pTa (%) 12 (13%)
 pT1 (%) 30 (33%) NA
 pT2 (%) 28 (30%)
 pT3/T4 (%) 22 (24%)
Grade
 Low (%) 34 (37%)
 High (%) 46 (50%) NA
 Unknown (%) 12 (13%)